Alkermes plc (ALKS) Tops Q3 EPS by 3c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. XYZ
8. CVS
9. SPY
10. SWKS

Go back to Alkermes plc (ALKS) Tops Q3 EPS by 3c

Alkermes plc Reports Third Quarter 2015 Financial Results

October 29, 2015 7:02 AM EDT

Third Quarter Revenues of $152.7 Million and Non-GAAP Diluted Loss Per Share of $0.18

Commercial Launch of ARISTADA Underway Following FDA Approval for the Treatment of Schizophrenia on Oct. 5, 2015

ALKS 3831 for Schizophrenia and ALKS 8700 for Multiple Sclerosis to Commence Registration Studies Before Year-End

DUBLIN--(BUSINESS WIRE)-- Alkermes plc (NASDAQ: ALKS) today reported financial results for... More